About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
Sequencing Chemotherapy as a First and Second-Line Treatment of Metastatic Pancreatic Cancer - What Do We Know?
By
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019
FEATURING
Darren Sigal
By
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019
FEATURING
Darren Sigal
1,072 views
May 30, 2019
0 Comments
Login to view comments.
Click here to Login
Featured Video
15:07
Exelixis
Safety and Efficacy Data of a TKI Monotherapy in HCC
Feat.
J. Mizrahi
Featured Video
20:00
Exelixis
Child-Pugh Classification and its Role in Treatment Decisions in Pat…
Feat.
P. Gholam
Related Content
AUTOPLAY
ON
27:37
ASCO GI 2023 Conference Coverage
ASCO GI 2023 Expert Panel Discussion: Practice-Changing Updates
Feat.
N. Uboha,
A. Turk,
K. Spencer,
M. Cecchini
23:58
ASCO GI 2023 Conference Coverage
ASCO GI 2023 Key Studies
Feat.
R. Kim,
R. Mehta
20:07
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Summary: "GI Expert Panel Discussion on Key Trials I…
Feat.
Y. Janjigian,
S. Cytryn,
S. Maron
03:50
UCLA Health
Perspectives on the Recent FDA Approval of NALIRIFOX in Frontline Me…
Feat.
Z. Wainberg
12:08
Yale Cancer Center
GI Oncology Year in Review: Precision Medicine Update in Metastatic …
Feat.
J. Lacy
07:53
Total Health
Updates on Pancreatic Cancer - 2023 ASCO® Direct Philadelphia
Feat.
D. Lin
30:55
2023 Johns Hopkins Updates in Gastrointestinal Cancers
Medical Oncology Updates in Pancreas Cancer
Feat.
T. Bekaii-Saab
08:08
Integrity Continuing Education
Updates in Nonmetastatic Upper-GI Adenocarcinoma
Feat.
J. Hernandez
06:28
Shubham Pant
FDA Approval of Liposomal Irinotecan/NALIRIFOX in 1L Metastatic Panc…
17:05
Insights from 2023 ESMO Annual Meeting
ESMO 2023 Insights: "A Multicenter, Randomized, Open-Label, Thr…
Feat.
A. Ohba
22:10
Yale Cancer Center
Pancreatic Cancer Updates From Yale Cancer Center
Feat.
J. Lacy
25:56
OncoAlert
Year in Review: Pancreatic Cancers
Feat.
M. Lewis
10:53
Yale Cancer Center
GI Oncology Year in Review: Metastatic Pancreatic Cancer - NAPOLI-3 …
Feat.
J. Lacy
18:35
Rachna Shroff
Augmenting Standard Treatment Options in Pancreatic Cancer
15:25
Scripps MD Anderson Cancer Center
Pancreatic Cancer Trials - Evolving Landscape and Treatment Guidance
Feat.
J. Hecht
07:42
Integrity Continuing Education
Debates in Neoadjuvant Therapy in Resectable Pancreatic Cancer: Why …
Feat.
W. Burns
06:16
ecancer
ASCO® 2023 Insights: "NAPOLI 3 Analysis of 1L NALIRIFOX vs. Gem…
Feat.
E. O’Reilly
10:41
ASCO GI 2023 Conference Coverage
ASCO GI 2023 NAPOLI-3 Randomized, Open-Label Phase 3 Study: Liposoma…
Feat.
Z. Wainberg
08:03
Insights from 2023 ESMO World Congress on Gastrointestinal Cancer Annual Meeting
2023 ESMO WCGIC Insights: "Additional Results From the Phase 3 …
Feat.
Z. Wainberg
23:32
The University of Kansas Cancer Center
Updates on Pancreatic Cancer Treatment
Feat.
A. Kasi
